Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DEAF1 Antikörper (AA 73-200) (HRP)

DEAF1 Reaktivität: Human ELISA Wirt: Kaninchen Polyclonal HRP
Produktnummer ABIN7149607
  • Target Alle DEAF1 Antikörper anzeigen
    DEAF1 (Deformed Epidermal Autoregulatory Factor 1 (Drosophila) (DEAF1))
    Bindungsspezifität
    • 15
    • 11
    • 8
    • 7
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 73-200
    Reaktivität
    • 52
    • 26
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 62
    • 6
    Kaninchen
    Klonalität
    • 63
    • 5
    Polyklonal
    Konjugat
    • 28
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser DEAF1 Antikörper ist konjugiert mit HRP
    Applikation
    • 57
    • 34
    • 13
    • 6
    • 3
    • 2
    • 2
    • 1
    ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Deformed epidermal autoregulatory factor 1 homolog protein (73-200AA)
    Isotyp
    IgG
    Top Product
    Discover our top product DEAF1 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    DEAF1 (Deformed Epidermal Autoregulatory Factor 1 (Drosophila) (DEAF1))
    Andere Bezeichnung
    DEAF1 (DEAF1 Produkte)
    Synonyme
    AU042387 antikoerper, C230009B13Rik antikoerper, NUDR antikoerper, SPN antikoerper, ZMYND5 antikoerper, MYND5 antikoerper, spn antikoerper, DEAF1 antikoerper, nudr antikoerper, zmynd5 antikoerper, CG8567 antikoerper, DEAF-1 antikoerper, Deaf-1 antikoerper, Dmel\\CG8567 antikoerper, deaf1 antikoerper, l(3)76BDv antikoerper, deformed epidermal autoregulatory factor 1 (Drosophila) antikoerper, DEAF1, transcription factor antikoerper, DEAF1 transcription factor antikoerper, deformed epidermal autoregulatory factor 1 homolog antikoerper, Deformed epidermal autoregulatory factor-1 antikoerper, Deaf1 antikoerper, DEAF1 antikoerper, LOC509260 antikoerper, deaf1 antikoerper, deaf-1 antikoerper
    Hintergrund

    Background: Transcription factor that binds to sequence with multiple copies of 5\'-TTC[CG]G-3\' present in its own promoter and that of the HNRPA2B1 gene. Down-regulates transcription of these genes. Binds to the retinoic acid response element (RARE) 5\'-AGGGTTCACCGAAAGTTCA-3\'. Activates the proenkephalin gene independently of promoter binding, probably through protein-protein interaction. When secreted, behaves as an inhibitor of cell proliferation, by arresting cells in the G0 or G1 phase. Required for neural tube closure and skeletal patterning. Regulates epithelial cell proliferation and side-branching in the mammary gland. Controls the expression of peripheral tissue antigens in pancreatic lymph nodes. Isoform 1 displays greater transcriptional activity than isoform 4. Isoform 4 may inhibit transcriptional activity of isoform 1 by interacting with isoform 1 and retaining it in the cytoplasm. Transcriptional activator of EIF4G3.

    Aliases: Deaf1 antibody, DEAF1 transcription factor antibody, DEAF1_HUMAN antibody, Deformed epidermal autoregulatory factor 1 homolog antibody, Nuclear DEA1 related transcriptional regulator antibody, Nuclear DEAF-1-related transcriptional regulator antibody, NUDR antibody, SPN antibody, Suppressin antibody, Zinc finger MYND domain containing protein 5 antibody, Zinc finger MYND domain-containing protein 5 antibody, ZMYND5 antibody

    UniProt
    O75398
    Pathways
    Tube Formation
Sie sind hier: